TransMedics (NASDAQ: TMDX) is on a mission to revolutionize the organ transplant process. Thanks to the company's Organ Care System (OCS), TransMedics' equipment essentially keeps donated livers, ...
TransMedics shares fell 25% pre-market after a disappointing Q3 report, missing revenue and EPS estimates, with management failing to manage expectations. Read more here.